Besremi (Ropeginterferon

Besremi is an interferon alfa-2b used for the treatment of adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells. 

Recommended Dosage: The recommended starting dose is 100 mcg by subcutaneous injection every 2 weeks (50 mcg if receiving hydroxyurea). Increase the dose of besremi injection by 50 mcg every 2 weeks (up to a maximum of 500 mcg) until hematological parameters are stabilized. Interrupt or discontinue dosing in case certain adverse reactions occur.

• Severe or fatal neuropsychiatric reactions have occurred in patients receiving interferon alfa products, including Ropeginterferon alfa-2b-njft.
• Precisely assess patients for any symptoms of psychiatric disorders and consider psychiatric consultation and treatment if such symptoms occurs. In case psychiatric symptoms worsen, it is recommended to discontinue besremi 500 mcg therapy.
• Endocrine toxicity has emerged in patients taking treatment with interferon alfa products, including Ropeginterferon alfa-2b-njft. Do not use this drug in patients with active serious or untreated endocrine disorders associated with autoimmune disease. 
• Assess thyroid function in patients who develop signs/symptoms suggestive of thyroid disease during Ropeginterferon alfa-2b-njft therapy. Discontinue this therapy in patients who develop endocrine disorders that are difficult to manage during treatment.
• Reduced peripheral blood counts have noted in patients taking treatment with interferon alfa products, including besremi 500 mcg injection. Monitor complete blood counts, during titration and every 3 to 6 months during the maintenance phase. Assess patients for signs/symptoms of infection or bleeding.
• Hyperlipidemia has emerged in patients treated with interferon alfa products, including Ropeginterferon alfa-2b-njft. Assess serum triglycerides prior to and during therapy and manage when elevated.
• Pregnancy testing is recommended prior to Ropeginterferon alfa-2b-njft treatment in females of reproductive age or potential. 

What documents are required to import BESREMi to India?

BESREMi (ropeginterferon alfa-2b njft) injection can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

• Valid prescription letter from a qualified doctor.
• Patient’s diagnostic reports.
• Patient’s Identity Proof (issued by Government of India).

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription from the doctor.
• Import permit if applicable.

Is BESREMi available in India?

BESREMi (ropeginterferon alfa-2b njft injection) is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds facilitates:

• Availability of BESREMi in India (Ahmedabad, Mumbai, Kolkata, Hyderabad, Chennai, Delhi, Bangalore, Pune, etc.).
• Medicine price.
• Finding genuine and reliable sources from Canada, Europe, USA, and Australia.
• Ensuring 100% transparency.

BESREMi can be made available to patients, doctors, and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

Urgent Meds can facilitate the supply of BESREMi (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).

Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for BESREMi 500 mcg price in India.

We guarantee the quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing BESREMi (Medicines from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.